|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award
» Project Summaries
» Prizes - Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 2007 Independent Investigators  Mount Sinai School of Medicine Preclinical Investigation for the Treatment of Post-traumatic Stress Disorder (PTSD): Disruption of Traumatic Memories after their Reactivation Amit Anand, M.D. Indiana University fMRI and Genotype Markers of Antidepressant Side Effects and Response in Young Adults Susan S. Bassett, Ph.D. Johns Hopkins University Effects of Herpes Simplex Virus Type 1 Status on Brain Structure and Function in Patients with Bipolar Disorder Serge Beaulieu, M.D., Ph.D. McGill University Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish the Efficacy and Safety Yuly Bersudsky, M.D., Ph.D. Ben Gurion University Oxygen Therapy in Schizophrenia Miki Bloch, M.D. Sourasky Tel Aviv Medical Center Tel Aviv University Treatment of Postpartum Depression with Psychotherapy and Add-on Sertraline: A Double-Blind, Randomized, Placebo-Controlled Study Catalin V. Buhusi, Ph.D. Medical University of South Carolina CHL1 Deficits and Schizophrenia: Pharmacology and Behavior William A. Carlezon, Jr., Ph.D. Harvard Medical School Harvard University Role of Sprouty in the Development and Relief of Depression K.N. Roy Chengappa, M.D., FRCP Western Psychiatric Institute and Clinic University of Pittsburgh Sensoril : An Extract of a Medicinal Plant - Withania Somnifera for Cognitive Enhancement in Persons with Bipolar Disorder: A Parallel Group, Double Blind, Randomized, and Placebo Controlled Study David Cotter, M.D., MRCPsych, Ph.D. Royal College of Surgeons in Ireland Proteomic Analysis of Hippocampus in Schizophrenia and Bipolar Lynette C. Daws, Ph.D. University of Texas Health Science Center at San Antonio Stress-Related Affective Disorders: A Novel Role for Organic Cation Transporters Esteban C. Dell'Angelica, Ph.D. University of California, Los Angeles Biological Plausibility of DTNBP1 (dysbindin) as a Schizophrenia Susceptibility Gene Marisa E. Domino, Ph.D. University of North Carolina-Chapel Hill The Role of Medicare Part D in the Treatment of Serious Mental Illness Vicki L. Ellingrod, Ph.D. The Regents of the University of Michigan on behalf of the Medical Center Folate Pharmacogenomics and Metabolic Complications from Atypical Antipsychtoic Use in Bipolar Disorder Yue Feng, Ph.D. Emory University The Role of the RNA-binding Protein QKI in Schizophrenia Sergueï O. Fetissov, M.D., Ph.D. INSERM Universite Paris VI Anorexia Nervosa and Bulimia: Role of Autoantibodies Directed against Neuropeptides in Brain Mechanisms of Appetite and Emotion Bonnie L. Firestein, Ph.D. Rutgers University The Role of CAPON, A Gene Linked to Schizophrenia and Bipolar Disorder, in Neuronal Development Beng-Choon Ho, M.D. University of Iowa College of Medicine Adult Neurogenesis in Young, Nonpsychotic Relatives of Schizophrenia Probands - Hippocampal Dysfunction and Proneural bHLH Transcription Factor Genes Daniel P. Holschneider, M.D. University of Southern California Mapping Functional Brain Activation in Mice Lacking the Serotonin Transporter: Effects of Stress Sensitization in the Development of Mood Disorders Flavio P. Kapczinski, M.D., Ph.D. Federal University Serum Brain-derived Neurotrophic Factor as a Biomarker of Treatment Response in Bipolar Depression and Mania: A 16-week Follow-up Study Michal Lavidor, Ph.D. Bar-Ilan University Impaired Emotion Cue Decoding in Patients with Schizophrenia: TMS Studies of its Neuroanatomy, Lateralisation, and Remediation Deborah L. Levy, Ph.D. McLean Hospital Harvard University Identifying Endophenotypes for Bipolar Disorder Colleen K. Loo, M.D., MB.BS., FRANZCP University of New South Wales A Double-blind, Randomised, Placebo Controlled Trial of Adjunctive Ketamine as a Neuroprotective Agent in Electroconvulsive Therapy (ECT) Sonia J. Lupien, Ph.D. Douglas Hospital Research Centre McGill University Stress-Induced Vulnerability to Depression during Adolescence : Evaluating the Efficacy of the DeStress for Success Program Andrew Makoff, Ph.D. Institute of Psychiatry/King's College London University of London Investigation into Variants in the CHRNA7 Region of 15q13-q14 that Predispose to the P50 Sensory Gating Deficit: An Endophenotype of the Major Psychoses Kelsey C. Martin, M.D., Ph.D. University of California, Los Angeles A Cell Culture Model of Memory Reconsolidation Daniel H. Mathalon, M.D., Ph.D. Yale School of Medicine Yale University Intermittent D1 Agonist Treatment of Cognitive Deficits and Underlying Prefrontal Cortical Dysfunction in Schizophrenia: Tracking Treatment Effects with fMRI Alexandre Maucuer, Ph.D. INSERM Universite Paris VI Functional Characterization of the Protein Kinase KIS, Product of the Schizophrenia Susceptibility Gene UHMK1 Kathleen B. McDermott, Ph.D. Washington University School of Medicine Washington University Neural Substrates of Remembering and Episodic Future Thought in Schizophrenia Roger S. McIntyre, M.D., FRCPC University of Toronto A Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Major Depressive Disorder Tanya K. Murphy, M.D. University of Florida Double-blind Placebo Controlled Trial of Antibiotic Treatment for New Onset Pediatric Neuropsychiatric Disorders Pradeep J. Nathan, Ph.D. Monash University Effects of Intranasal Oxytocin on Amygdala Response to Fear in Social Anxiety Disorder Alexander Neumeister, M.D. Yale University Contribution of Early Life Trauma on Serotonin 1b Receptor Expression in Depression Stéphane H. R. Oliet, Ph.D. INSERM University Victor Segalen Bordeaux II Contribution of Glia-derived D-serine to NMDA Receptor Function Neil M. Richtand, M.D., Ph.D. Psychiatric Professional Services, Inc. University of Cincinnati Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Essential Fatty Acid Deficiency Replacement in Early Schizophrenia Uwe Rudolph, M.D. McLean Hospital Harvard University Role of GABAA Receptor Subtypes in Depression Bernardo L. Sabatini, M.D., Ph.D. Harvard Medical School Harvard University Long-term Synaptic Conseqeunces of Perturbations of NMDA-type Glutamate Receptors Tammy J. Sajdyk, Ph.D. Indiana University Neuropeptide Y-induced Stress Resilience in Adolescent Rats Gerard Sanacora, M.D., Ph.D. Yale University The Effects of Stress and Antidepressants on Amino Acid Neurotransmission and Glial Cell Function Jeremy K. Seamans, Ph.D. University of British Columbia COMT Modulation of PFC Networks in a Rat Model of Schizophrenia Eric P. Slade, Ph.D. University of Maryland Do Medicaid Prescription Drug Copayments Impede Use of Psychotropic Medications Among Persons With Serious Mental Illness? Iris E.C. Sommer, M.D., Ph.D. University Hospital Utrecht Utrecht University Genetic Study of Schizophrenia using Cerebral Lateralization as Endophenotype. (Genetic Linkage Study of Left-handedness and Language Lateralization in Extended Pedigrees from a Dutch Population Isolate) Qun-Yong Zhou, Ph.D. University of California, Irvine Signaling Role of Prokineticin 2 in Behavioral Responses Under Stress Yimin Zou, Ph.D. University of California, San Diego The Function and Mechanism of DISC1 in Mediating Axon Growth and Guidance » View Independent Investigator Award Recipients from
|
Announcements
NARSAD Award Winners
Latest News from NARSAD
|
Grantee List
Mei Huang, Ph.D., Vanderbilt University Medical Center, 2005 & 2007 Young Investigator